American Journal of Physiology-Heart and Circulatory Physiology · 2001 · 85 citations · 39 references
Life SciencesPharmacologyPhysiologyCell SignalingMolecular PharmacologySignal TransductionCardiovascular DevelopmentFetal PhysiologyG Protein-coupled Receptor SignalingMembrane ReceptorsReceptor PhysiologyReceptor RegulationAtp DependenceCamp SignalingG Protein-coupled Hormone ReceptorsGestation PeriodGestation PhysiologyRadioligand Binding AssaysReceptor Subtype SpecificityReceptors
Although the role of PGE2 in maintaining ductus arteriosus (DA) patency is well established, the specific PGE2 receptor subtype(s) (EP) involved have not been clearly identified. We used late gestation fetal and neonatal lambs to study developmental regulation of EP receptors. In the fetal DA, radioligand binding and RT-PCR assays virtually failed to detect EP1 but detected EP2, EP3D, and EP4 receptors in equivalent proportions. In the newborn lamb, DA total density was one-third of that found in the fetus and only EP2 was detected. Stimulation of EP2 and EP4 increased cAMP formation and was associated with DA relaxation. Though stimulation of EP3 inhibited cAMP formation, it surprisingly relaxed the fetal DA both in vitro and in vivo. This EP3-induced relaxation was specifically diminished by the ATP-sensitive K(+) (K(ATP)) channel blocker glibenclamide. In conclusion, PGE2 dilates the late gestation fetal DA through pathways that involve either cAMP (EP2 and EP4) or K(ATP) channels (EP3). The loss of EP3 and EP4 receptors in the newborn DA is consistent with its decreased responsiveness to PGE2.
39
Mark Abramovitz, Mohammed Adam, Yves Boie et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2000 · 557 citations · Full text